Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 826 AL 840

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease

Villa C, Stoccoro A.

Genes (Basel). 2022 Jul 22;13(8):1308. doi: 10.3390/genes13081308.

Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study

Bullich S, Mueller A, De Santi S, Koglin N, Krause S, Kaplow J, Kanekiyo M, Roé-Vellvé N, Perrotin A, Jovalekic A, Scott D, Gee M, Stephens A, Irizarry M.

Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x.

Association between Human Blood Metabolome and the Risk of Alzheimer's Disease

Sun L, Guo D, Jia Y, Shi M, Yang P, Wang Y, Liu F, Chen GC, Zhang Y, Zhu Z.

Ann Neurol. 2022 Nov;92(5):756-767. doi: 10.1002/ana.26464. Epub 2022 Aug 15.

Prospective biomarkers of Alzheimer's disease: A systematic review and meta-analysis

Li RX, Ma YH, Tan L, Yu JT.

Ageing Res Rev. 2022 Nov;81:101699. doi: 10.1016/j.arr.2022.101699. Epub 2022 Jul 26.

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease

Hansson O, Edelmayer RM, Boxer AL, Carrillo MC, Mielke MM, Rabinovici GD, Salloway S, Sperling R, Zetterberg H, Teunissen CE.

Alzheimers Dement. 2022 Dec;18(12):2669-2686. doi: 10.1002/alz.12756. Epub 2022 Jul 31.

Artificial intelligence in dementia

Richardson A, Robbins CB, Wisely CE, Henao R, Grewal DS, Fekrat S.

Curr Opin Ophthalmol. 2022 Sep 1;33(5):425-431. doi: 10.1097/ICU.0000000000000881.

Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults

Akinci M, Peña-Gómez C, Operto G, Fuentes-Julian S, Deulofeu C, Sánchez-Benavides G, Milà-Alomà M, Grau-Rivera O, Gramunt N, Navarro A, Minguillón C, Fauria K, Suridjan I, Kollmorgen G, Bayfield A, Blennow K, Zetterberg H, Molinuevo JL, Suárez-Calvet M, Gispert JD, Arenaza-Urquijo EM; ALFA Study.

Neurology. 2022 Oct 4;99(14):e1486-e1498. doi: 10.1212/WNL.0000000000200948. Epub 2022 Aug 2.

Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease

Prins S, de Kam ML, Teunissen CE, Groeneveld GJ.

Alzheimers Res Ther. 2022 Aug 3;14(1):106. doi: 10.1186/s13195-022-01051-2.

The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All

Rosen AC, Arias JJ, Ashford JW, Blacker D, Chhatwal JP, Chin NA, Clark L, Denny SS, Goldman JS, Gleason CE, Grill JD, Heidebrink JL, Henderson VW, Lavacot JA, Lingler JH, Menon M, Nosheny RL, Oliveira FF, Parker MW, Rahman-Filipiak A, Revoori A, Rumbaugh MC, Sanchez DL, Schindler SE, Schwarz CG, Toy L, Tyrone J, Walter S, Wang LS, Wijsman EM, Zallen DT, Aggarwal NT; members of AGREEDementia.

J Alzheimers Dis. 2022;90(3):953-962. doi: 10.3233/JAD-220458.

CD33 isoforms in microglia and Alzheimer's disease: Friend and foe

Eskandari-Sedighi G, Jung J, Macauley MS.

Mol Aspects Med. 2023 Apr;90:101111. doi: 10.1016/j.mam.2022.101111. Epub 2022 Aug 5.

Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer's disease

Vandendriessche C, Kapogiannis D, Vandenbroucke RE.

Adv Drug Deliv Rev. 2022 Nov;190:114486. doi: 10.1016/j.addr.2022.114486. Epub 2022 Aug 8.

Biomarkers for the Diagnosis of Alzheimer's Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria

Dulewicz M, Kulczyńska-Przybik A, Mroczko P, Kornhuber J, Lewczuk P, Mroczko B.

Int J Mol Sci. 2022 Aug 2;23(15):8598. doi: 10.3390/ijms23158598.

The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort

Puig-Pijoan A, García-Escobar G, Fernández-Lebrero A, Manero-Borràs RM, Sánchez-Benavides G, Navalpotro-Gómez I, Cascales Lahoz D, Suárez-Calvet M, Grau-Rivera O, Boltes Alandí A, Pont-Sunyer MC, Ortiz-Gil J, Carrillo-Molina S, López-Villegas D, Abellán-Vidal MT, Martínez-Casamitjana MI, Hernández-Sánchez JJ, Peña-Casanova J, Roquer J, Padrós Fluvià A, Puente-Périz V.

Neurologia (Engl Ed). 2024 Nov-Dec;39(9):756-765. doi: 10.1016/j.nrleng.2022.05.002. Epub 2022 Aug 9.

A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study

Verde F, Aiello EN, Milone I, Giacopuzzi Grigoli E, Dubini A, Ratti A, Poletti B, Ticozzi N, Silani V.

Neurol Sci. 2022 Nov;43(11):6547-6550. doi: 10.1007/s10072-022-06346-8. Epub 2022 Aug 16.

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy

Oberstein TJ, Schmidt MA, Florvaag A, Haas AL, Siegmann EM, Olm P, Utz J, Spitzer P, Doerfler A, Lewczuk P, Kornhuber J, Maler JM.

Brain. 2022 Nov 21;145(11):4032-4041. doi: 10.1093/brain/awac297.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias